NCT00260338View on ClinicalTrials.gov

Stem Cell Therapy for Vasculogenesis in Patients With Severe Myocardial Ischemia

PHASE1/PHASE2CompletedINTERVENTIONAL
Enrollment

31

Participants

Timeline

Start Date

December 31, 2005

Primary Completion Date

July 31, 2009

Study Completion Date

July 31, 2009

Conditions
Myocardial IschemiaCoronary Heart Disease
Interventions
BIOLOGICAL

stem cell

mesenchymal stromal cell

Trial Locations (1)

2100

Cardiovascular Lab. 2014, The Heart Centre, Rigshospitalet, Blegdamcvej 9, Copenhagen

All Listed Sponsors
lead

Rigshospitalet, Denmark

OTHER

NCT00260338 - Stem Cell Therapy for Vasculogenesis in Patients With Severe Myocardial Ischemia | Biotech Hunter | Biotech Hunter